Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions.
Individualized treatments with combination of radiotherapy and targeted drugs require knowledge about the behavior of molecular targets after irradiation. Angiogenic marker expression has been studied after conventional radiotherapy, but little is known about marker response to charged particles. For the very first time, we used molecular ultrasound imaging to intraindividually track changes in angiogenic marker expression after carbon ion irradiation in experimental tumors. Expression of intercellular adhesion molecule-1 (ICAM-1) and of alpha(v)beta(3)-integrin in subcutaneous AT-1 prostate cancers in rats treated with carbon ions (16 Gy) was studied using molecular ultrasound and immunohistochemistry. For this purpose, cyanoacrylate microbubbles were synthesized and linked to specific ligands. The accumulation of targeted microbubbles in tumors was quantified before and 36 hours after irradiation. In addition, tumor vascularization was analyzed using volumetric Doppler ultrasound. In tumors, the accumulation of targeted microbubbles was significantly higher than in nonspecific ones and could be inhibited competitively. Before irradiation, no difference in binding of alpha(v)beta(3)-integrin-specific or ICAM-1-specific microbubbles was observed in treated and untreated animals. After irradiation, however, treated animals showed a significantly higher binding of alpha(v)beta(3)-integrin-specific microbubbles and an enhanced binding of ICAM-1-specific microbubbles than untreated controls. In both groups, a decrease in vascularization occurred during tumor growth, but no significant difference was observed between irradiated and nonirradiated tumors. In conclusion, carbon ion irradiation upregulates ICAM-1 and alpha(v)beta(3)-integrin expression in tumor neovasculature. Molecular ultrasound can indicate the regulation of these markers and thus may help to identify the optimal drugs and time points in individualized therapy regimens.
Palmowski
Moritz
M
Institute of Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany. mpalmowski@ukaachen.de
Peschke
Peter
P
Huppert
Jochen
J
Hauff
Peter
P
Reinhardt
Michael
M
Maurer
Mathias
M
Karger
Christian P
CP
Scholz
Michael
M
Semmler
Wolfhard
W
Huber
Peter E
PE
Kiessling
Fabian M
FM
D000818:Animals; D002250:Carbon Radioisotopes; D007124:Immunoenzyme Techniques; D039302:Integrin alphaVbeta3 / Q000378:metabolism*; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D008297:Male; D045423:Microbubbles; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000532:radiotherapy; D011471:Prostatic Neoplasms / Q000098:blood supply*; D051381:Rats; D011923:Rats, Nude; D018608:Ultrasonography, Doppler; D023041:Xenograft Model Antitumor Assays
D002250:Carbon Radioisotopes; D039302:Integrin alphaVbeta3; D018799:Intercellular Adhesion Molecule-1